FCP
MDT icon

Fidelis Capital Partners’s Medtronic MDT Stock Holding History

Fidelis Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,047
Closed -$264K – 547
2026
Q1 		$264K Sell
3,047
-2,767
-48% -$265K 0.02% 428
2025
Q4 		$558K Sell
5,814
-1,347
-19% -$131K 0.04% 290
2025
Q3 		$682K Buy
7,161
+4,404
+160% +$405K 0.05% 253
2025
Q2 		$246K Sell
2,757
-383
-12% -$32.5K 0.02% 384
2025
Q1 		$264K Sell
3,140
-3
-0.1% -$268 0.03% 345
2024
Q4 		$285K Buy
3,143
+720
+30% +$62.3K 0.03% 343
2024
Q3 		$224K Buy
+2,423
New +$204K 0.03% 371
2024
Q2 		– Sell
-4,678
Closed -$408K – 394
2024
Q1 		$408K Buy
4,678
+1,061
+29% +$90.5K 0.06% 236
2023
Q4 		$298K Sell
3,617
-67
-2% -$5.11K 0.07% 245
2023
Q3 		$293K Buy
3,684
+884
+32% +$74K 0.1% 199
2023
Q2 		$247K Buy
+2,800
New +$241K 0.09% 231

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fidelis Capital Partners's MDT Position: Q2 2026 in Review

Fidelis Capital Partners sold out of Medtronic (MDT) in Q2 2026, closing a stake of 3,047 shares — an estimated $264K sold.

Fidelis Capital Partners first reported a position in MDT in Q2 2023 and held it in 11 quarters. The position peaked at $682K in Q3 2025. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Fidelis Capital Partners reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
  • Fidelis Capital Partners sold 3,047 Medtronic shares in Q2 2026, an estimated $264K.
  • Fidelis Capital Partners first reported a position in Medtronic in Q2 2023 and held it in 11 quarters.
  • Fidelis Capital Partners's Medtronic position peaked at $682K in Q3 2025.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.